Passage Bio (PASG) News Today → Trump convicted... now what? (From Stansberry Research) (Ad) Free PASG Stock Alerts $1.13 -0.06 (-4.64%) (As of 12:39 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | americanbankingnews.comAnalyzing Passage Bio (NASDAQ:PASG) & Sana Biotechnology (NASDAQ:SANA)June 5, 2024 | globenewswire.comPassage Bio to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceJune 1, 2024 | americanbankingnews.comChardan Capital Analysts Increase Earnings Estimates for Passage Bio, Inc. (NASDAQ:PASG)May 31, 2024 | marketbeat.comFY2024 Earnings Estimate for Passage Bio, Inc. Issued By Chardan Capital (NASDAQ:PASG)Passage Bio, Inc. (NASDAQ:PASG - Free Report) - Equities research analysts at Chardan Capital raised their FY2024 earnings per share estimates for Passage Bio in a report released on Tuesday, May 28th. Chardan Capital analyst Y. Livshits now anticipates that the company will earn ($1.12) per sharMay 21, 2024 | globenewswire.comPassage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardMay 15, 2024 | markets.businessinsider.comOptimistic Outlook for Passage Bio Amid Clinical and Financial Progress: Maintains Buy RatingMay 15, 2024 | msn.comPassage Bio Reports Promising Interim Data in FTD-GRN Treatment TrialMay 15, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Price Target Cut to $13.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group lowered their price objective on Passage Bio from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday.May 15, 2024 | marketbeat.comPassage Bio, Inc. (NASDAQ:PASG) Forecasted to Post Q1 2025 Earnings of ($0.20) Per SharePassage Bio, Inc. (NASDAQ:PASG - Free Report) - Investment analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for shares of Passage Bio in a research report issued on Tuesday, May 14th. Wedbush analyst L. Chico anticipates that the company will post earnings of ($0.20) peMay 14, 2024 | investorplace.comPASG Stock Earnings: Passage Bio Beats EPS for Q1 2024May 14, 2024 | globenewswire.comPassage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsApril 22, 2024 | finance.yahoo.comPassage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitApril 22, 2024 | globenewswire.comPassage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitMarch 29, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Trading Up 3.1%Passage Bio (NASDAQ:PASG) Trading Up 3.1%March 20, 2024 | finance.yahoo.comPASG Apr 2024 7.500 callMarch 16, 2024 | finance.yahoo.comPASG Apr 2024 5.000 callMarch 7, 2024 | marketbeat.comPassage Bio, Inc. (NASDAQ:PASG) Expected to Post Q1 2024 Earnings of ($0.33) Per SharePassage Bio, Inc. (NASDAQ:PASG - Free Report) - Equities researchers at Wedbush lifted their Q1 2024 earnings per share (EPS) estimates for shares of Passage Bio in a research note issued on Monday, March 4th. Wedbush analyst L. Chico now anticipates that the company will post earnings per shareMarch 6, 2024 | investorplace.comPASG Stock Earnings: Passage Bio Beats EPS for Q4 2023March 6, 2024 | marketbeat.comPassage Bio, Inc. to Post FY2028 Earnings of $0.05 Per Share, Wedbush Forecasts (NASDAQ:PASG)Passage Bio, Inc. (NASDAQ:PASG - Free Report) - Investment analysts at Wedbush issued their FY2028 earnings per share (EPS) estimates for shares of Passage Bio in a report issued on Monday, March 4th. Wedbush analyst L. Chico expects that the company will post earnings of $0.05 per share for theMarch 5, 2024 | marketbeat.comPassage Bio (NASDAQ:PASG) Given "Buy" Rating at Canaccord Genuity GroupCanaccord Genuity Group reiterated a "buy" rating and issued a $14.00 target price on shares of Passage Bio in a research report on Tuesday.March 5, 2024 | finance.yahoo.comPassage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramMarch 4, 2024 | globenewswire.comPassage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsMarch 3, 2024 | msn.comPassage Bio to Showcase Advancements at Major Health Care ConferencesMarch 3, 2024 | marketbeat.comPassage Bio (PASG) Set to Announce Quarterly Earnings on MondayPassage Bio (NASDAQ:PASG) will be releasing earnings on Monday, March 4, Yahoo Finance reports.February 27, 2024 | globenewswire.comPassage Bio to Participate in Upcoming Investor ConferencesFebruary 20, 2024 | investing.comPassage Bio Inc (PASG)February 16, 2024 | investing.comPASG/USD - Passage US DollarFebruary 12, 2024 | finance.yahoo.comWe Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth CarefullyFebruary 2, 2024 | msn.comPassage Bio CEO to Address Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceJanuary 31, 2024 | finance.yahoo.comPassage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceDecember 21, 2023 | benzinga.comPassage Bio Stock (NASDAQ:PASG) Dividends: History, Yield and DatesDecember 20, 2023 | msn.comNeurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic PrioritiesDecember 20, 2023 | markets.businessinsider.comPassage Bio Announces Initial Clinical Data From Phase 1/2 UpliFT-D Trial On PBFT02December 20, 2023 | finance.yahoo.comPassage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNovember 22, 2023 | morningstar.comPassage Bio Inc Ordinary SharesNovember 15, 2023 | benzinga.comPassage Bio Stock (NASDAQ:PASG) Earnings Dates and Earning CallsNovember 15, 2023 | markets.businessinsider.comPassage Bio Earns Buy Rating Based on Robust Financial Position and Promising AAV1-based GT PBFT02 TrialNovember 13, 2023 | fr.investing.comLe BPA de Passage Bio a manqué les attentes de 0,03$, le CA conforme aux prévisionsNovember 13, 2023 | msn.comPassage Bio GAAP EPS of -$0.49 misses by $0.03November 13, 2023 | benzinga.comRecap: Passage Bio Q3 EarningsNovember 13, 2023 | finance.yahoo.comPassage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNovember 10, 2023 | morningstar.comPassage Bio Inc Ordinary Shares PASGOctober 30, 2023 | benzinga.comPassage Bio to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology ConferenceOctober 30, 2023 | finance.yahoo.comPassage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceOctober 8, 2023 | news.yahoo.comVenezuelan migrants pay for passage to Trinidad with sex workSeptember 25, 2023 | benzinga.comPassage Bio to Present at Chardan's 7th Annual Genetic Medicines ConferenceSeptember 25, 2023 | finance.yahoo.comPassage Bio to Present at Chardan’s 7th Annual Genetic Medicines ConferenceSeptember 5, 2023 | finance.yahoo.comIs Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?August 11, 2023 | finance.yahoo.comLab Notes: Almac Group starts work on $65M Montco expansion expected to create 355 jobsAugust 9, 2023 | nasdaq.comChardan Capital Maintains Passage Bio (PASG) Buy Recommendation Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution PASG Media Mentions By Week PASG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PASG News Sentiment▼0.330.76▲Average Medical News Sentiment PASG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PASG Articles This Week▼21▲PASG Articles Average Week Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALGS News SLDB News TNYA News GNFT News BDTX News PSTX News IPSC News ADAP News MGX News CADL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PASG) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored